biontech + turkovac Search Results


turkovac  (BioNTech)
90
BioNTech turkovac
Memory B cell responses induced by <t>TURKOVAC</t> vaccination. The absolute number of spike-specific memory B cells (A) , IgM+ (B) , and IgG+ (C) B cells per 5 × 10 5 PBMCs before and after vaccinations. Red, green, and blue indicate all volunteers, volunteers with two doses of vaccination, and volunteers with three doses of vaccination, respectively. Values are expressed as arithmetic mean and standard deviation; p † indicates the significance for between-group comparisons; p ‡ indicates the significance for within-group comparisons. All baseline values were one (1.00) before the transformation. Standard deviation statistic was not calculated, thus this time point was not included in within-group comparisons. Since shifted logarithmic transformation (log(x + 1)) was applied, this quantity, as well as the mean statistic, is computed as 0.30. Significant p values are shown in bold.
Turkovac, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/turkovac/product/BioNTech
Average 90 stars, based on 1 article reviews
turkovac - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
biontech + turkovac  (BioNTech)
90
BioNTech biontech + turkovac
Study Group Descriptives
Biontech + Turkovac, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biontech + turkovac/product/BioNTech
Average 90 stars, based on 1 article reviews
biontech + turkovac - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Memory B cell responses induced by TURKOVAC vaccination. The absolute number of spike-specific memory B cells (A) , IgM+ (B) , and IgG+ (C) B cells per 5 × 10 5 PBMCs before and after vaccinations. Red, green, and blue indicate all volunteers, volunteers with two doses of vaccination, and volunteers with three doses of vaccination, respectively. Values are expressed as arithmetic mean and standard deviation; p † indicates the significance for between-group comparisons; p ‡ indicates the significance for within-group comparisons. All baseline values were one (1.00) before the transformation. Standard deviation statistic was not calculated, thus this time point was not included in within-group comparisons. Since shifted logarithmic transformation (log(x + 1)) was applied, this quantity, as well as the mean statistic, is computed as 0.30. Significant p values are shown in bold.

Journal: Frontiers in Medicine

Article Title: Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months

doi: 10.3389/fmed.2025.1524393

Figure Lengend Snippet: Memory B cell responses induced by TURKOVAC vaccination. The absolute number of spike-specific memory B cells (A) , IgM+ (B) , and IgG+ (C) B cells per 5 × 10 5 PBMCs before and after vaccinations. Red, green, and blue indicate all volunteers, volunteers with two doses of vaccination, and volunteers with three doses of vaccination, respectively. Values are expressed as arithmetic mean and standard deviation; p † indicates the significance for between-group comparisons; p ‡ indicates the significance for within-group comparisons. All baseline values were one (1.00) before the transformation. Standard deviation statistic was not calculated, thus this time point was not included in within-group comparisons. Since shifted logarithmic transformation (log(x + 1)) was applied, this quantity, as well as the mean statistic, is computed as 0.30. Significant p values are shown in bold.

Article Snippet: Comparison of our results with those of BioNTech and other vaccine platforms indicates that immunization with TURKOVAC is successfully able to induce the expansion of spike-specific B cell clones and memory B cells, which may persist for up to 8 months post-vaccination.

Techniques: Standard Deviation, Transformation Assay

Study Group Descriptives

Journal: Anatolian Journal of Cardiology

Article Title: Comparison of the Effects of Recent Coronavirus 2019 Infection and Vaccination on the Prognosis of Acute Coronary Syndrome: A Retrospective Study Conducted in a Single Center in Türkiye

doi: 10.14744/AnatolJCardiol.2024.4372

Figure Lengend Snippet: Study Group Descriptives

Article Snippet: Biontech + Turkovac , 9 (0.68%) , 0 (0.00%)*.

Techniques: Filtration

Summary of Variables with Regard to Major Adverse Cardiac Event

Journal: Anatolian Journal of Cardiology

Article Title: Comparison of the Effects of Recent Coronavirus 2019 Infection and Vaccination on the Prognosis of Acute Coronary Syndrome: A Retrospective Study Conducted in a Single Center in Türkiye

doi: 10.14744/AnatolJCardiol.2024.4372

Figure Lengend Snippet: Summary of Variables with Regard to Major Adverse Cardiac Event

Article Snippet: Biontech + Turkovac , 9 (0.68%) , 0 (0.00%)*.

Techniques: Filtration